Insmed, Inc. (INSM)

195.26 +5.41 (+2.85%) USD  |  NASDAQ  |  Dec 11, 16:00
197.00 +1.74 (+0.89%) After-Hours: 20:00
More

Insmed Research and Development Expense (TTM): 695.91M for Sept. 30, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for INSM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Pfizer Inc. 10.13B
United Therapeutics Corp. 544.30M
Alnylam Pharmaceuticals, Inc. 1.248B
Madrigal Pharmaceuticals, Inc. 296.43M
Vertex Pharmaceuticals, Inc. 3.954B